Measuring Preferences for Colorectal Cancer Screening: What are the Implications for Moving Forward?

By Marshall Deborah   McGregor S. Elizabeth   Currie Gillian  

The Patient: Patient-Centered Outcomes Research, Vol. 3, Iss. 2, 2010-06 ,pp. : 79-89

Adis International

Access to resources Recommend Favorite

Early Detection of Breast Cancer: New Biomarker Tests on the Horizon?

By Jotwani Aparna C.  

Molecular Diagnosis & Therapy, Vol. 13, Iss. 6, 2009-12 ,pp. : 349-357

Adis International

Access to resources Recommend Favorite

Stress and Quality of Life in Breast Cancer Recurrence: Moderation or Mediation of Coping?

By Yang Hae-Chung  

Annals of Behavioral Medicine, Vol. 35, Iss. 2, 2008-04 ,pp. : 188-197

Springer Publishing Company

Access to resources Recommend Favorite

Prostate cancer and the PCP: the screening dilemma

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 12, 2015-12 ,pp. : 1438-1447

John Wiley & Sons Inc

Access to resources Recommend Favorite

Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen

By Fleeman Nigel   Payne Katherine   Newman William G   Howell Sacha J   Boland Angela   Oyee James   Saborido Carlos Martin   Santander Ana Fernández   Dickson Rumona  

Personalized Medicine, Vol. 10, Iss. 6, 2013-08 ,pp. : 601-611

Future Medicine

Access to resources Recommend Favorite